710
I.L. Odinets et al. / Journal of Organometallic Chemistry 690 (2005) 704–712
(1JPC ꢀ7, C0 ), 128.49 (3JPC = 2.8, C0 ), 128.55 (C0 ),
272 ([Cp*RhCl ꢁ H]+, 10), 237 ([Cp*Rh ꢁ H]+, 18),
134 ([Cp* ꢁ H]+, 27). Anal. Calc. for C22H28Cl4RhP:
C, 46.51; H, 4.97; P, 5.45. Found: C, 46.16, 46.48; H,
5.21, 5.17; P, 5.80, 5.87%.
1
3
4
129.97 (2JPC = 4.0, C60 ), 139.71 (2JPC = 18.6, C02); FAB-
MS, M+ found = 273.0346, C13H16Cl2P requires
273.0367 for the 35Cl isotopes.
Compound 2c-anti: 31P NMR (CDCl3) d 27.9 (60%),
13C NMR (CDCl3) d 21.1 (C1–CH3), 21.3 (3JPC = 23.1,
Ar–CH3), 37.4 (1JPC = 16.9, C2), 39.3 (1JPC = 14.6, C4),
39.8 (2JPC = 5.7, C5), 45.2 (2JPC = 5.3, C1), C6 over-
lapped with the signals of CDCl3, 125.83 (C05), 128.43–
128.49 (C01 and C03 of both isomers overlapped), 128.75
(C04), 130.29 (2JPC = 4.2, C60 ), 135.48 (2JPC = 13.1, C02).
The total yield for the two isomers of 2c is 100%.
Compound 5: 31P NMR (C6D6) d –30.6; 13C NMR
(C6D6) d 23.1 (3JPC = 5.6, CH3), 128.7 (1JPC = 8.2, C2),
129.8 (C04), 131.8 (3JPC = 16.0, C03), 134.4 (1JPC = 16.2,
C10 ), 134.5 (2JPC = 21.5, C20 ), 134.7 (C3), 136.8
(3JPC = 11.4, C4), 144.4 (C7); FAB-MS, M+
found = 283.0191; C14H14Cl2P requires 283.0210 for
the 35Cl isotopes.
Compound 3b-syn: yield: 87%; m.p. 187–188 ꢁC; 31P
NMR (CDCl3) d 70.6 (JPRh = 136.6); 13C NMR
(CDCl3) d 8.6 (CP*–CH3), 20.2 (3JPC = 7.2, C1–CH3),
21.3 (Ar–CH3), 30.4 (1JPC = 31.7, C4), 36.4
(1JPC = 30.3, C2), 42.0 (C1), 43.2 (C5), 72.2 (C6), 98.0
(1JCRh = 4.1, Cp*), 128.6 (3JPC = 9.9, C03), 129.4
1
(1JPC = 33.7, C01) 130.8 (2JPC = 8.2, C20 ), 140.5 (C04); H
NMR (CDCl3) d 1.39 (d, 15H, CH3–Cp*, J = 3.6);
1.60 (s, 3H, CH3–C1), 1.99 (dd, 1H, C2–Hb,
2
2JHH = 8.0, JPH = 18.0), 2.34 (s, 3H, m-CH3–Ar), 2.64
2
2
(dd, 1H, cis-C2–Ha, JHH = 7.0, JPH = 15.2), 2.86 (part
of ABDX system, 1H, C4–Hb, J = 8.8, 8.8, 14.8), 2.96
(part of ABDX system, 1H, C4–HB, J = 7.2, 7.2, 14.8),
3.29 (m, 1H, C5–H), 5.27 (2H, CH2Cl2-solvate), 7.17
3
(d, 2H, o-C6H4CH3, JHH = 7.2), 7.68 (d, 1H, m-
3
C6H4CH3, JHH = 7.2), 7.71 (d, 1H, m-C6H4CH3,
3.3. Preparation of rhodium (III) complexes 3a–c and 6
3JHH = 7.2); Anal. Calc. for C23H30Cl4RhP Æ CH2Cl2:
C, 43.21; H, 4.83. Found: C, 43.18; H, 4.74%.
To the solution of 0.30 mmol of ligand 2a–c in 6 ml of
CH2Cl2 was added 89 mg (0.14 mmol) of [Cp*RhCl2]2 in
10 ml of CH2Cl2 at 25 ꢁC over a period of 10–15 min.
The red solution formed immediately was stirred for
0.5 h. According to 31P NMR, the formation of the
complex(es) was completed during this time. In the case
of 2c, the mixtures of isomers of the starting phosphines
were used in the ratio 2csyn:2c-anti = 95:5 and 38:62 to
obtain 3c-syn and 3c-anti, respectively. Then the solvent
was evaporated to dryness and 3 ml of CH2Cl2 was
added. The mixture was filtered and ꢀ1 ml of pentane
was added dropwise to the filtrate. The solution was al-
lowed to stand at 26 ꢁC for overnight. The red crystals
precipitated from the solution were filtered off and dried
in vacuo. For isolation of 3c-anti, the precipitated 35:75
mixture of the two 3c isomers was again recrystallized
using the same system of solvents (CH2Cl2-pentane).
Compound 3a-syn: yield: 87%; m.p. 191–195 ꢁC; 31P
NMR (CDCl3) d 70.3 (JPRh = 137.3), 13C NMR
(CDCl3) d 8.6 (Cp*–CH3), 20.1 (3JPC = 6.6, C1–CH3),
30.3 (1JPC = 31.5, C4), 36.3 (1JPC = 30.1, C2), 42.0 (C1),
43.1 (C5), 72.1 (C6), 98.0 (CP*), 127.9 (3JPC = 9.6, C30 ),
130.2 (4JPC = 2.5, C40 ), 130.7 (2JPC = 7.8, C20 ), 133.0
(1JPC = 31.0, C10 ); 1H NMR (CDCl3) d 1.42 (d, 15H,
CH3–Cp*, J = 3.6); 1.63 (s, 3H, CH3), 2.23 (dd, 1H,
Compound 3c-syn: yield: 67%; m.p. 169–170 ꢁC; 31P
NMR (CDCl3) d 67.8 (1JPRh = 139.9); 13C NMR
(CDCl3) d 8.5 (Cp*–CH3), 20.2 (C1–CH3), 22.8 (Ar–
CH3), 30.0 (C4), 34.5 (C2), 44.0 (C5), 73.9 (C6), 98.1
(Cp*), 124.75 (2JPC = 7.8, C60 ), 130.3 (C04), 130.5
(1JPC = 108.5, C01), 130.7 (3JPC = 4.5, C03), 131.5
1
(3JPC = 8.4, C05), 141.7 (2JPC = 10.2, C02–Me); H NMR
(CDCl3) d 1.35 (d, 15H, CH3–Cp*, J = 3.6), 1.59 (s,
3H, CH3–C1), 1.95–2.06 (br.m, 1H, C2–H), 2.50 (br.s,
4H, o-CH3–Ar overlapped with C2–H), 2.92–3.12
(br.m, 2H, C2–H2), 3.62–3.70 (br.m, 1H, C5–H), 5.27
3
(2H, CH2Cl2-solvate), 7.21 (d, 1H, C06-H, JHH = 7.4),
3
7.24 (d, 1H, C02–H, JHH = 7.2), 7.35 (dd, 1H, C05–H,
3
3JHH = 7.4, 7.6), 7.50 (t, 1H, C40 –H, JHH = 7.6). Anal.
Calc. for C23H30Cl4RhP: C, 47.45; H, 5.19. Found: C,
47.75, 47.60; H, 5.19, 5.27%.
Compound 3c-anti: yield: 32%; m.p.: 166–168 ꢁC; 31
P
NMR (CDCl3) d 91.6 (1JPRh = 143.4); 13C NMR
(CDCl3) 20.7 (C1–CH3), 22.6 (Ar–CH3), 29.5 (C4),
34.2 (1JPC = 27.4, C2), 40.4 (C1), 41.9 (C5), 75.1
(3JPC = 14.0, C6), 98.6 (d, Cp*, J = 2.6), 125.4
(2JPC = 6.8, C06), 130.9 (C40 ), 130.5 (1JPC = 88.5, C01),
131.4 (3JPC = 8.4, C50 ), 131.6 (3JPC = 8.6, C50 ), 132.3
(2JPC = 8.0, C20 –Me); Anal. Calc. for C23H30Cl4RhP: C,
47.45; H, 5.19. Found: C, 47.85; H, 5.08%.
2
2
C2–Hb, JHH = 7.6, JPH = 18.4), 2.70 (dd, 1H, cis-C2–
Complex 6 was obtained by the analogous procedure
using the appropriate amounts of [Cp*RhCl2]2 and
phosphine 5. Yield: 80%; m.p. >350 ꢁC; 31P NMR
(CDCl3) d –0.89 (1JRhP = 142.1); 13C NMR (CDCl3) d
8,7 (CH3–Cp*), 22.9 (3JPC =9.3, C8), 98.3 (Cp*), 121.7
(1JPC = 48.9, C2), 127.0 (1JPC = 86.0, C01-ipso), 127.8
(3JPC = 10.2, C30 ), 130.2 (C40 ), 131.1 (3JPC = 42.5, C4),
131.6 (3JPC = 9.2, C20 ), 140.4 (C3), and 152.4
2
2
Ha, JHH = 7.6, JPH = 15.2), 2.90 (part of ABDX sys-
tem, 1H, C4–Hb, J = 8.4, 8.4, 14.8), 3.01 (part of ABDX
system, 1H, C4–HB, J = 7.6, 7.6, 14.8), 3.32 (m, 1H, C5–
H, J = 8.4, 8.0, 14.8), 7.35–7.39 and 7.81–7.85 (2m,
3H + 2H,
Ph).
MS,
m/z
(rel.
int.)
258
([M ꢁ Cp*RhCl2]+, 6), 223 ([M ꢁ Cp*RhCl2 ꢁ Cl]+,
30), 187 ([M ꢁ Cp*RhCl2 ꢁ Cl ꢁ HCl]+, 9) and inde-
pendently 308 ([Cp*RhCl2]+, 8), 273 ([Cp*RhCl]+, 8),
1
(4JPC = 8.8, C7); H NMR (CDCl3) d 1.49 (d, CH3Cp*,